DarioHealth Corp. (DRIO)

1,6100 -0,0200 (-1,23%) Alla chiusura: 04:00PM EDT

DarioHealth Corp.

122 W 57th St,
#33B
New York, NY 10019
United States

https://www.dariohealth.com

Settore/i: Healthcare
Settore: Health Information Services
Impiegati a tempo pieno: 276

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Erez Raphael	CEO & Director	722,19k	N/D	1973
Mr. Richard A. Anderson	President	536,65k	N/D	1969
Mr. Zvi Ben David CPA	CFO, Treasurer & Secretary	342,58k	N/D	1961
Dov Oppenheim	Co-Founder & Production Chief	N/D	N/D	N/D
Mr. Tomer Ben-Kiki	Chief Operating Officer	N/D	N/D	1971
Josh Fischer	Senior Vice President of Operations & Compliance	N/D	N/D	N/D
Claudia Levi	Content & Communications Manager	N/D	N/D	N/D
Mary Mooney	Vice President of Marketing	N/D	N/D	N/D
Limor Drezner	Chief People Officer	N/D	N/D	N/D
Mr. Jean Christophe Muyl	Head of Commercialization North America	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Governance aziendale

L'ISS Governance QualityScore di DarioHealth Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.